University of Strathclyde
The MSc in Cancer Therapies is unique in the UK. ?It's a multifaceted ?course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology.? You'll also get an understanding of the practical, ethical and economic implications of personalised cancer therapy.? The degree is for graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies. ? You'll be taught in the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK?. The Institute has major facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit - the only one of its kind in the UK. You'll threrefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas.? Studying with us will provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade - from target evaluation and engagement to clinical trials.The course will also provide you with the specialist research training and a breadth of skills needed for your future career. The masters degree has been designed in response to a growing demand from academia, industry and health care providers for a course which focuses on current and emerging cancer therapies, in a format which covers essential multidisciplinary aspects of the topic.
MSc: Minimum second class honours degree or international equivalent in a science or health related subject. Students with alternative entry standards or professional experience may also be considered and are usually admitted in the first instance to the diploma course. Upon satisfactory completion of all semester 1 assessment, these students will be offered the chance to transfer to the MSc programme. You must have an English language minimum score of IELTS 6.0 (with no component below 5.5).
Advanced Techniques in Biomedical Research 1&2; Generic Research Skills; Entrepreneurship, Innovation & Commercialisation; Development and Design of Anti-Cancer Drugs; Targeted Cancer Therapies for Personalised Medicine; Radiobiology and Radiation Oncology: From Beam to Bedside; Drug Discovery and Development in Cancer; Scientific Writing; Research Project.
Written examinations, course work with formative and summative approaches are taken in different aspects of the course. Written reports, oral presentations, scenario-based learning and moderated peer assessment are all included in the course.
|Qualification||Study mode||Start month||Fee||Course duration|
|MSc||Full-time||September 2019||19,500 per Whole course (International)||12 Months|
|MSc||Full-time||September 2019||8,100 per Whole course (Home/EU)||12 Months|
|MSc||Part-time||September 2019||8,100 per Whole course (Home/EU)||24 Months|
|MSc||Part-time||September 2019||19,500 per Whole course (International)||24 Months|
|Campus name||Town||Postcode||Region||Main campus||Campus||Partner|
|University of Strathclyde||G1 1XQ||Scotland|
Get in touch
Remember to mention TARGETpostgrad when contacting universities.
Postgraduate Admissions - Faculty of Science